- Home
- DSGN vs RITR Comparison
DSGN vs RITR Comparison
Compare DSGN & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- RITR
- Stock Information
- Founded
- DSGN 2017
- RITR 2015
- Country
- DSGN United States
- RITR Hong Kong
- Employees
- DSGN N/A
- RITR N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- RITR
- Sector
- DSGN Health Care
- RITR
- Exchange
- DSGN Nasdaq
- RITR NYSE
- Market Cap
- DSGN 208.9M
- RITR 221.1M
- IPO Year
- DSGN 2021
- RITR 2024
- Fundamental
- Price
- DSGN $3.77
- RITR $5.09
- Analyst Decision
- DSGN Hold
- RITR
- Analyst Count
- DSGN 1
- RITR 0
- Target Price
- DSGN $4.00
- RITR N/A
- AVG Volume (30 Days)
- DSGN 82.2K
- RITR 980.6K
- Earning Date
- DSGN 08-04-2025
- RITR 02-15-2025
- Dividend Yield
- DSGN N/A
- RITR N/A
- EPS Growth
- DSGN N/A
- RITR N/A
- EPS
- DSGN N/A
- RITR 0.09
- Revenue
- DSGN N/A
- RITR $47,948,887.00
- Revenue This Year
- DSGN N/A
- RITR N/A
- Revenue Next Year
- DSGN N/A
- RITR N/A
- P/E Ratio
- DSGN N/A
- RITR $61.54
- Revenue Growth
- DSGN N/A
- RITR 278.44
- 52 Week Low
- DSGN $2.60
- RITR $2.24
- 52 Week High
- DSGN $7.77
- RITR $8.75
- Technical
- Relative Strength Index (RSI)
- DSGN 49.66
- RITR N/A
- Support Level
- DSGN $3.33
- RITR N/A
- Resistance Level
- DSGN $4.21
- RITR N/A
- Average True Range (ATR)
- DSGN 0.24
- RITR 0.00
- MACD
- DSGN -0.02
- RITR 0.00
- Stochastic Oscillator
- DSGN 50.29
- RITR 0.00
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About RITR REITAR LOGTECH HLDGS LTD
Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.